Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Research Progress on Marine Active Substances in Improving Atherosclerosis.

  • 2026-05-06
  • Marine drugs 24(5)
    • Chenyang Xie
    • Jiapeng Qi
    • Wenmei Huang
    • Bei Chen
    • Min Xu
    • Shuji Liu
    • Yongchang Su
    • Yixiong Lin
    • Kun Qiao
    • Zhiyu Liu

Study Design

Type
Review
Atherosclerosis is the primary pathological foundation of various cardiovascular and cerebrovascular diseases. Although existing treatment strategies exhibit certain efficacy, they still encounter limitations such as pronounced side effects and a single-target approach. The oceans have nurtured a rich diversity of organisms, and the secondary metabolites they generate possess novel structures, diverse activities, and unique mechanisms of action, offering new prospects for the development of anti-atherosclerotic drugs. This paper reviews advancements related to research on marine-derived active substances that possess anti-atherosclerotic activity, as well as current challenges in research on active substances, with the objective of laying a foundation for the development of anti-atherosclerotic drugs.

Research Insights

    Back to top